Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced RET Fusion–Positive Non–Small Cell Lung Cancer

26 Mar 20265 min read0 viewsJournal Feed

GIST

Journal of Clinical Oncology, Volume 44, Issue 13 , Page 1190-1197, May 2026.

Clinical Editorial

Summary

Journal of Clinical Oncology (JCO) published a clinical update in Oncology on 26 Mar 2026. The item focuses on Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced RET Fusion–Positive Non–Small Cell Lung Cancer. Open the detail page to review the full original feed content.